SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Acquired by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. boosted its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 13.6% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 85,068 shares of the exchange traded fund’s stock after buying an additional 10,168 shares during the quarter. Oppenheimer & Co. Inc. owned 0.11% of SPDR S&P Biotech ETF worth $8,405,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Concurrent Investment Advisors LLC boosted its holdings in SPDR S&P Biotech ETF by 13.2% during the first quarter. Concurrent Investment Advisors LLC now owns 2,564 shares of the exchange traded fund’s stock worth $243,000 after buying an additional 299 shares in the last quarter. Avantax Advisory Services Inc. grew its position in shares of SPDR S&P Biotech ETF by 17.2% in the first quarter. Avantax Advisory Services Inc. now owns 9,619 shares of the exchange traded fund’s stock valued at $913,000 after purchasing an additional 1,415 shares during the period. Kingsview Wealth Management LLC increased its stake in shares of SPDR S&P Biotech ETF by 3.8% during the first quarter. Kingsview Wealth Management LLC now owns 3,495 shares of the exchange traded fund’s stock worth $332,000 after purchasing an additional 127 shares in the last quarter. HBK Sorce Advisory LLC raised its position in shares of SPDR S&P Biotech ETF by 2.6% during the 1st quarter. HBK Sorce Advisory LLC now owns 4,538 shares of the exchange traded fund’s stock worth $431,000 after purchasing an additional 113 shares during the last quarter. Finally, Blair William & Co. IL lifted its stake in SPDR S&P Biotech ETF by 42.7% in the 1st quarter. Blair William & Co. IL now owns 150,562 shares of the exchange traded fund’s stock valued at $14,287,000 after buying an additional 45,053 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI opened at $100.01 on Thursday. The stock has a 50 day moving average price of $99.07 and a 200 day moving average price of $95.98. The stock has a market capitalization of $7.62 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a one year low of $69.32 and a one year high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.